Search - tctmd.com

Displaying 41 - 60 of 176

Sort: Relevancy | Date

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Debate: CT-FFR Will Replace Most Diagnostic Catheterizations!

Presenter: Pamela S. Douglas, Paul S. Teirstein, Jonathon A. Leipsic

October 30, 2017

Presentation TCT 2017

Debate: Invasive Angiography With Coronary Physiology and Intravascular Imaging Trumps Noninvasive Imaging!

Presenter: Pamela S. Douglas, Paul S. Teirstein, Justin E. Davies

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Evaluation of Suspected Coronary Artery Disease With Non-invasive and Invasive Imaging: What Do the US Guidelines and AUC Say?

Presenter: Pamela S. Douglas, Paul S. Teirstein, James K. Min

October 30, 2017

Presentation TCT 2017

Evaluation of Suspected Coronary Artery Disease With Noninvasive and Invasive Imaging: What Do the Data and EU Guidelines Say?

Presenter: Pamela S. Douglas, Paul S. Teirstein, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

Presenter: Robert A. Guyton

October 30, 2017

Presentation TCT 2017

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Presenter: Anthony H. Gershlick

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Roman Tarasov

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

Presenter: Gregg W. Stone, Suzanne J. Baron

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Conclusion - How I Treated This Case

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Presentation TCT 2017

Germany Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Advertisement

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Debate: CT-FFR Will Replace Most Diagnostic Catheterizations!

Debate: Invasive Angiography With Coronary Physiology and Intravascular Imaging Trumps Noninvasive Imaging!

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Evaluation of Suspected Coronary Artery Disease With Non-invasive and Invasive Imaging: What Do the US Guidelines and AUC Say?

Evaluation of Suspected Coronary Artery Disease With Noninvasive and Invasive Imaging: What Do the Data and EU Guidelines Say?

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Why Are Hypertension and Coronary Artery Disease So Connected?

Live From Denver: TCT 2017, Day One

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Slovakia Presents: Case Conclusion - How I Treated This Case

Germany Comments: How Would I Treat This Case and Why?

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content